Articles On Telix Pharmaceuticals (ASX:TLX)

MELBOURNE, Australia, Feb. 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the financial year ended 31 December 2022. All figures are in AU$ unless otherwise...

A three-week retreat in Australian shares looks set to continue this morning following falls on Wall Street after a rebound in inflation sharpened the risk of a return to jumbo interest rate hikes.   The S&P/ASX 200 will open 51 poin...

Trial met primary and secondary endpoints and confirmed favourable safety and tolerability profile, indicating TLX250-CDx has the potential to become a new clinical standard in the identification and characterisation of clear cell renal...

Highlights A new 100-day high for ASX 200 was noted at market close on 1 February 2023. The ASX 200 was up, gaining 0.33% to 7,501.70. Over the past five days, ASX 200 has gained 0.45%. Top performers of the day included Flight Centr...

ASX health stocks rise 4.6% this week with positive signs of being back in favour Volpara soars after announcing its first net cash flow positive quarter Morgans basket of healthcare stock picks for 2023 faring well,  all up YTD Healthca...

The S&P/ASX 200 Index (ASX: XJO) wobbled in and out of the green on Wednesday before ultimately closing 0.1% higher at 7,393.4 points. Providing the biggest boost was the tech sector. The S&P/ASX 200 Information Technology Index (A...

The share market inched to a new eight-and-a-half-month high as a strong start to the year continued. The S&P/ASX 200 rose seven points or 0.1 per cent to 7393.4. Buying in the closing auction helped avert the first back-to-back loss...

The ASX closed flat on Wednesday Local investors are closely watching earnings reports in both the US and Australia EU to release inflation report tonight   The ASX 200 was subdued on Wednesday as investors weighed earnings results in the...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.1% to 7,396.1 points. Four ASX shares that are climbing more than most today are listed below...

Australian shares marked time for a second day as a mixed night on Wall Street gave investors few reasons to add to positions at an eight-month high. The S&P/ASX 200 nudged up seven points or 0.1 per cent by mid-session. Healthcar...

MELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ — 18 January 2023. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarte...

It’s a good day to own S&P/ASX 200 Index (ASX: XJO) biotech share Telix Pharmaceuticals Ltd (ASX: TLX). The company just revealed it has surpassed a major milestone towards profitability – positive cash flow. The Telix share price...

World Overnight SPI Overnight 7348.00 – 21.00 – 0.28% S&P ASX 200 7386.30 – 1.90 – 0.03% S&P500 3990.97 – 8.12 – 0.20% Nasdaq Comp 11095.11 + 15.96 0.14% DJIA 33910.85 – 391.76 – 1.14% S&P500 VIX 19.36 – 0.13 – 0.6...

ASX health stocks rise 0.8% this week as smaller names in sector show signs of being back in favour Volpara signs five 5-year contracts worth more than US$7.8 million in Total Contract Value Mach 7 continues its 2023 recovery after announc...

ShareCafeAlmost all sectors lower despite signs of optimism in the US: ASX down 0.3% at noon by Peter Milios   Overnight Chris Zaccarelli, Chief Investing Officer at the Independent Advisor Alliance, stated, “Today is another one of those d...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end its winning streak. At the time of writing, the benchmark index is down 0.2% to 7,137.1 points. Four ASX shares that are falling more than most today are listed...

The share market sealed its longest win run since early November with a fourth straight rise following strong gains on Wall Street as buyers bet on a soft landing for the US economy. The S&P/ASX 200 trimmed its advance as iron ore pr...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decent gain. At the time of writing, the benchmark index is up 0.55% to 7,148.9 points. Four ASX shares that have failed to follow the market hi...

Aussie shares hit a three-week high amid optimism about cooling inflation and China reopening. The S&P/ASX 200 rallied 44 points or 0.62 per cent by mid-session. The advance put the Australian benchmark on track for a fourth straight...

MELBOURNE, Australia, Jan. 9, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P. Morgan Healthcare Conference (9 – 12 January) in San Francisco. As pa...

The share market snapped a run of four straight weekly declines following reports China may relax restrictions on property developers. The S&P/ASX 200 rallied 46 points or 0.65 per cent this afternoon to its third straight gain of th...

Resource stocks steered the ASX towards a third day of gains and a winning week to start 2023 despite pressure on Wall Street. The S&P/ASX 200 climbed 35 points or 0.5 per cent by mid-session. The heavily-weighted materials sector...

ASX 200 benchmark climbs 1.5% during an otherwise super-quiet day Tesla dives 12.2% and Apple slips back under US$2T market cap Extra-special bonus: The greatest sporting achievement we’re gonna see all year   Welcome to the end of the fi...

The S&P/ASX 200 Index (ASX: XJO) recovered from Tuesday’s fall today, lifting 1.63% to close at 7,059.2 points. Its gains came despite a rough night’s trade on Wall Street. The Dow Jones Industrial Average Index (DJX: .DJI) traded...

The ASX had its first positive day of gains in 2023 Tesla could still be overpriced despite a 70% fall – expert US Fed meeting minutes due out tonight   The ASX recorded its first day of gains for the year as financial and tech stocks led...

A new year got off to a challenging start with Australian stocks at eight-week lows as a month-long retreat continued in the wake of soft economic signals from major trading partner China.   The S&P/ASX 200 slumped 92.5 points or 1.3...

If you’re interested in adding some healthcare sector exposure to your portfolio, then it could be worth taking a look at what Bell Potter is recommending. It has named its top picks in the healthcare sector for 2023 and the two ASX heal...

The share market slumped to an eight-week low as signs of a sharp slowdown in major trading partner China offset positive leads from European stocks. At the halfway mark, the S&P/ASX 200 was down 127 points or 1.81 per cent after a b...

Soaring inflation and rising interest rates plagued share markets in 2022, ultimately sending the S&P/ASX 200 Index (ASX: XJO) down 5.5%. Despite being known for their defensive qualities, ASX 200 healthcare shares weren’t spared fro...

Ending the year on a high note, the S&P/ASX 200 Index (ASX: XJO) rallied on the last trading day of 2022. The benchmark index climbed 0.26% to 7,038.7 points, following in the footsteps of the US stock market last night. Nearly all se...

If investors weren’t already sick of 2022, today’s performance of the S&P/ASX 200 Index (ASX: XJO) was yet another nudge to the downside. By the end of the day, the benchmark index was 0.94% lower at 7,020.1 points. While the rest of...

Highights The ASX 200 benchmark index closed in the red today (December 29), losing 69.00 points or 0.97% to end at 7,017.40 points. The index has lost 1.89% over the last five days, and 6.56% over the last 52 weeks. Energy was the wo...

The share market closed at a seven-week low following solid falls on Wall Street amid fears of another challenging year ahead as rising interest rates crimp corporate profits. The S&P/ASX 200 dropped 66 points or 0.94 per cent to its...

Thursday was another good day on the S&P/ASX 200 Index (ASX: XJO). It closed 0.53% higher at 7,152.5 points. In the lead today was the S&P/ASX 200 Utilities Index (ASX: XUJ). The sector soared 1.6% as all three of its constituents...

Complete data from global Phase III ZIRCON study of Telix’s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be presented at American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancer...

The long and short of 2022 is that it was a frustrating period for the Australian biotech sector but one with its fair share of rewards as the sector’s exponents furthered worthy drugs, diagnostics, devices and doodahs. For the sixth year,...

The S&P/ASX 200 Index (ASX: XJO) traded in the green on Tuesday, recovering some of yesterday’s slump. At the end of today’s session, the index was 0.31% higher at 7,203.3 points Tech shares were among the market’s best performe...

MELBOURNE, Australia, Dec. 5, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces several key executive leadership appointments and promotions, reflecting the increased commercial focus of the...

Owen Rask and Drew Meredith are back on The Australian Investors Podcast for 2 Sense. This week, Drew and Owen talk crypto, getting financial advice, SMSFs, IVV’s stock split and JP Morgan Asset Management’s 10 year macro outlook. And of co...

According to Oxford Languages, ‘motley’ means “incongruously varied in appearance or character”. But in relation to our Foolish writers, it means they vary greatly with regard to age, risk tolerance, and stage of life as well as in...

The S&P/ASX 200 Index (ASX: XJO) recovered yesterday’s slump and then some today. It closed Tuesday’s session 0.59% higher at 7,181.3 points. That’s despite major commodities, including oil, iron ore, and gold all having fallen o...

MELBOURNE, Australia, Nov. 22, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase II investigator-initiated study of TLX101 in combination with...

The S&P/ASX 200 Index (ASX: XJO) slipped on Tuesday as lithium stocks weighed on the market. The index closed 0.07% lower at 7,141.6 points. It followed a weak session on Wall Street overnight in which the Dow Jones Industrial Average...

Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage:

Telix Pharmaceuticals (TLX) enters an agreement with Northern California PET Imaging Center to acquire radiochemistry specialist Optimal TracersThe company believes the acquisition will “bolster” its in-house radiochemistry development capa...

Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage:

Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage:

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a volatile day. The biopharmaceutical company’s shares were pushing higher in early trade but have now dropped into the red. At the time of writing, the Telix share price is...

MELBOURNE, Australia and INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Sacramento-based Northern California PET Im...

It might be hard to believe after a crazy volatile 2022, but the S&P/ASX 200 Index (ASX: XJO) is still well up since the start of the COVID-19 pandemic.  However, according to Wilsons equity strategist Rob Crookston, there is one usual...